Canopy Growth Corporation

WEED

CA1380357048

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Canopy Growth Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

9.76 CAD

Average target price

8.412 CAD

Spread / Average Target

-13.81%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
CANOPY GROWTH CORPORATION	+44.38%	543M
DONG-E-E-JIAO CO.,LTD.	+41.52%	6.2B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-23.06%	4.09B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+11.98%	3.48B
TASLY PHARMACEUTICAL GROUP CO., LTD	-19.68%	2.82B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.52%	2.28B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+45.53%	1.94B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-8.31%	1.51B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+48.41%	1.53B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-19.16%	1.47B

Alternative Medicine

Market Closed - Toronto S.E. Other stock markets 16:00:00 2024-06-06 EDT			5-day change	1st Jan Change
9.76 ^CAD	-8.36%		-17.15%	+44.38%

06-06	Acreage Closes US$10-Million Private Placement of Convertible-Debenture Units	MT
06-06	Toronto Stocks Edge Higher; Transcontinental Rises on Higher 2Q Adjusted Profit	DJ

Acreage Closes US$10-Million Private Placement of Convertible-Debenture Units	06-06	MT
Toronto Stocks Edge Higher; Transcontinental Rises on Higher 2Q Adjusted Profit	06-06	DJ
Canopy Growth Sets up $250 Million At-the-Market Equity Program; Shares Fall	06-06	MT
Canopy Growth Down 3% In US Premarket As Establishes US$250 Million At-The-Market Program To "Further Enhance the Company's Financial Position And Facilitate Growth"	06-06	MT
Canopy Growth Brief: Establishing US$250 Million At-The-Market Program To "Further Enhance the Company's Financial Position And Facilitate Growth"	06-06	MT
Acreage Entering into US$10 Million Private Placement; Comes Amid Transaction With Canopy Growth	06-05	MT
Acreage Brief: Entering into US$10 Million Private Placement	06-05	MT
Canopy Growth Exercises Option to Acquire Class E Shares of Acreage	06-04	MT
Canopy Growth Exercises Option to Acquire Acreage Class E Shares Following on 2019 Acquisition Agreement	06-04	MT
Canopy Growth Brief: Announcing Exercise of Acreage Options "Paving the Way" for Acquisition by Canopy USA	06-04	MT
Piper Sandler Reviews Canopy Growth's Q4	05-31	MT
Transcript : Canopy Growth Corporation, Q4 2024 Earnings Call, May 30, 2024	05-30
Canopy Growth Q4 Loss Narrows as Net Revenue Rises 7%	05-30	MT
Canopy Growth Brief: Q4 FY 2024 Net Revenue increased 7% year-over-year, or 16% excluding divested businesses	05-30	MT
Canopy Growth Corporation Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-30	CI
Canopy Growth Brief: Q4 Operating loss from continuing operations of $107 Million	05-30	MT
Canopy Growth Corporation Reports Earnings Results for the Full Year Ended March 31, 2024	05-30	CI
Pot stocks rise as US unveils proposal to ease restrictions on marijuana	05-16	RE
US Government Reclassifies Marijuana to Less-Restrictive Category	05-16	MT
Canopy Growth, Tilray Shares Rise After DOJ Proposes Marijuana Reclassification	05-16	DJ
Justice Department Set to Post Cannabis Reclassification Plans	05-16	MT
Investors wary of US cannabis ETFs despite recent rally	05-07	RE
Canopy USA Exercises Options to Acquire Wana, Jetty	05-07	MT
Canopy Growth Confirming Canopy USA's Exercise of Options to Acquire Wana and Jetty	05-07	MT
Canopy Growth Brief: Confirming Canopy USA's Exercise of Options to Acquire Wana and Jetty	05-07	MT